BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15153718)

  • 1. Methotrexate-induced leukoencephalopathy reversed by aminophylline and high-dose folinic acid.
    Jaksic W; Veljkovic D; Pozza C; Lewis I
    Acta Haematol; 2004; 111(4):230-2. PubMed ID: 15153718
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversal of neurologic disturbances related to high-dose methotrexate by aminophylline.
    Peyriere H; Poiree M; Cociglio M; Margueritte G; Hansel S; Hillaire-Buys D
    Med Pediatr Oncol; 2001 Jun; 36(6):662-4. PubMed ID: 11344503
    [No Abstract]   [Full Text] [Related]  

  • 3. Conventional and diffusion-weighted MRI findings of methotrexate related sub-acute neurotoxicity.
    Balin J; Parmar H; Kujawski L
    J Neurol Sci; 2008 Jun; 269(1-2):169-71. PubMed ID: 18191947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate-related neurotoxicity in the treatment of childhood acute lymphoblastic leukemia.
    Shuper A; Stark B; Kornreich L; Cohen IJ; Avrahami G; Yaniv I
    Isr Med Assoc J; 2002 Nov; 4(11):1050-3. PubMed ID: 12489505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient encephalopathy after intrathekal methotrexate chemotherapy: diffusion-weighted MRI.
    Küker W; Bader P; Herrlinger U; Heckl S; Nägele T
    J Neurooncol; 2005 May; 73(1):47-9. PubMed ID: 15933817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A woman who couldn't speak: report of methotrexate neurotoxicity.
    Szawarski P; Chapman CS
    Postgrad Med J; 2005 Mar; 81(953):194-5. PubMed ID: 15749798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurotoxicity due to methotrexate in paediatric patients. Description of the clinical symptoms and neuroimaging findings].
    Garcia-Puig M; Fons-Estupina MC; Rives-Sola S; Berrueco-Moreno R; Cruz-Martinez O; Campistol J
    Rev Neurol; 2012 Jun; 54(12):712-8. PubMed ID: 22673947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent intrathecal methotrexate induced neurotoxicity in an adolescent with acute lymphoblastic leukemia: Serial clinical and radiologic findings.
    Brugnoletti F; Morris EB; Laningham FH; Patay Z; Pauley JL; Pui CH; Jeha S; Inaba H
    Pediatr Blood Cancer; 2009 Feb; 52(2):293-5. PubMed ID: 18831032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.
    Bhojwani D; Sabin ND; Pei D; Yang JJ; Khan RB; Panetta JC; Krull KR; Inaba H; Rubnitz JE; Metzger ML; Howard SC; Ribeiro RC; Cheng C; Reddick WE; Jeha S; Sandlund JT; Evans WE; Pui CH; Relling MV
    J Clin Oncol; 2014 Mar; 32(9):949-59. PubMed ID: 24550419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose methotrexate-associated acute renal failure may be an avoidable complication.
    Fong CM; Lee AC
    Pediatr Hematol Oncol; 2006; 23(1):51-7. PubMed ID: 16326413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation and Management of Acute-Onset Hemiparesis in an Adolescent With Leukemia.
    Subrahmanian KN; Shim YH; Shah MD; Tran BH; Stevens AM; Cruz AT
    Pediatr Emerg Care; 2018 Mar; 34(3):e47-e50. PubMed ID: 27668914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rare complication of intrathecal methotrexate in a child with acute lymphoblastic leukemia.
    Tufekci O; Yilmaz S; Karapinar TH; Gozmen S; Cakmakci H; Hiz S; Irken G; Oren H
    Pediatr Hematol Oncol; 2011 Sep; 28(6):517-22. PubMed ID: 21699468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early diagnosis of leukoencephalopathy of acute lymphocytic leukemia by MRI.
    Ito M; Akiyama Y; Asato R; Kubota M; Kasai Y; Rios E; Mikawa H
    Pediatr Neurol; 1991; 7(6):436-9. PubMed ID: 1797008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Not Uncommon Cause of Stroke Mimicker in Children.
    Willis E; Samanta D; Kanfi A
    Pediatr Neurol; 2018 Mar; 80():92-93. PubMed ID: 29229230
    [No Abstract]   [Full Text] [Related]  

  • 15. How long can folinic acid rescue be delayed after high-dose methotrexate without toxicity?
    Cohen IJ; Wolff JE
    Pediatr Blood Cancer; 2014 Jan; 61(1):7-10. PubMed ID: 24038885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesial temporal sclerosis associated with methotrexate-induced leukoencephalopathy.
    Hamamoto K; Oriuchi N; Kanazawa T; Higuchi T; Endo K
    Pediatr Neurol; 2009 Apr; 40(4):306-9. PubMed ID: 19302946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications of tumour overkill when associated with high dose methotrexate therapy.
    Bell R; Forbes IK; Sullivan JR; Hurley TH
    Clin Exp Pharmacol Physiol Suppl; 1979; 5():47-55. PubMed ID: 400971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate-induced subacute neurotoxicity in a child with acute lymphoblastic leukemia carrying genetic polymorphisms related to folate homeostasis.
    Vagace JM; Caceres-Marzal C; Jimenez M; Casado MS; de Murillo SG; Gervasini G
    Am J Hematol; 2011 Jan; 86(1):98-101. PubMed ID: 21064136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posterior reversible encephalopathy syndrome associated with methotrexate neurotoxicity: conventional magnetic resonance and diffusion-weighted imaging findings.
    Dicuonzo F; Salvati A; Palma M; Lefons V; Lasalandra G; De Leonardis F; Santoro N
    J Child Neurol; 2009 Aug; 24(8):1013-8. PubMed ID: 19307676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative MRI assessment of leukoencephalopathy.
    Reddick WE; Glass JO; Langston JW; Helton KJ
    Magn Reson Med; 2002 May; 47(5):912-20. PubMed ID: 11979570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.